ABSTRACT Investigations of respiratory symptoms among workers in a factory producing polyurethane foam included measurement of air pollution with amines and isocyanates and a simultaneous health investigation of the exposed workers. An increased bronchial reactivity to inhaled methacholine was found in the study group compared with two unexposed control groups. This finding, together with visual disturbances in the exposed group, were assumed to be caused mainly by the volatile amines. The concentrations of isocyanates in air were well below 0-005 ppm. The amine concentration was 1000 to 10 000 times higher than the isocyanate concentration. The most volatile amine, N-methylmorpholine, occurred in the air in concentrations higher than 10 ppm. The results indicate that not only the isocyanates but also the amines might well be responsible for respiratory symptoms among exposed workers in polyurethane foam production. The occupational health problems associated with polyurethane production are mainly ascribed to the occurrence of isocyanates in the working atmosphere. The ability of isocyanates to cause bronchial hypersensitivity reactions is well known.'-10 The underlying mechanism is not fully understood, however, and the bronchial reactivity may be due to chemically irritant, immunological, or pharmacological mechanisms. Isocyanate-specific IgE antibodies have occasionally been shown in serum from sensitised workers'-'9
During the past 20 years polyurethanes have gained increasing industrial importance due to their excellent chemical and mechanical properties. They are made by reacting isocyanates with polyols (polyalcohols) in the presence of amines as catalysts and cross linking agents.
The occupational health problems associated with polyurethane production are mainly ascribed to the occurrence of isocyanates in the working atmosphere. The ability of isocyanates to cause bronchial hypersensitivity reactions is well known. '-10 The underlying mechanism is not fully understood, however, and the bronchial reactivity may be due to chemically irritant, immunological, or pharmacological mechanisms. Isocyanate-specific IgE antibodies have occasionally been shown in serum from sensitised workers '-'9 During the past five years we have studied adverse health effects associated with the production of polyurethanes. Several cases of isocyanate asthma have been diagnosed during that time, and we have also found antibodies to isocyanates in some of the patients when using a modified RAST (radio- Received 22 February 1982 Accepted 16 February 1983 allergosorbent test) method (L Belin and U Wass, unpublished data).
In some factories producing polyurethanes, especially those using MDI (4, 4'-Diphenylmethane diisocyanate), workers claimed to have respiratory symptoms although we found only very low levels of isocyanates (<0.0001 ppm), including phenyl isocyanate, in the working atmosphere when using a modem liquid chromatographic method for the analysis.20 This suggested the presence of respiratory tract irritants other than isocyanates in the working environment. Polyols are considered to have only a weak irritant effect on the airways mainly because of their low vapour pressures which limit the exposure by inhalation. Amines, on the other hand, are often volatile and are known respiratory irritants.2127 Thus dimethyl ethanol amine has been reported specifically to induce asthma and rhinitis in a spray painter.24 Furthermore, a group of 25 workers showed a significant decrease in lung function over a workshift when exposed to 3-dimethylamino propylamine By skin prick testing, those who developed immediate weal and flare reactions to one or more of the common aeroallergen extracts were classified as atopic subjects. The prick test panel included two isocyanate-HSA conjugates (MDI,TDI) that were also used in a RAST system to detect specific IgE antibodies in the serum. Methacholine inhalation challenges were performed by tidal breathing through a face mask of an aerosol containing first 1 mg and then 10 mg of methacholine (acetyl-,8-methylcholine chloride) generated by a Pari optimal nebuliser. One millilitre of each test solution was given by intermittent nebulisation over the inspiration. Each step was separated by a five minute observation period, including spirometry, and was preceded by a placebo challenge using 1 ml of saline. Forced expirations after maximal inspiration were recorded with an electronic Monagan M 403 spirometer to which a Houston X-Y recorder was connected. FEV, was directly read on a display and MEF4o (maximum expiratory flow when 40% of prechallenge vital capacity remained) was calculated from the flow volume curves produced by this instrument, assuming TLC (total lung capacity) to be unchanged throughout the test procedure. Thirty controls, matched for age and smoking but otherwise randomly selected, were taken from a workforce engaged in injection moulding of thermosetting materials (plastics) in an adjacent building. These controls (first control group) were not exposed to either isocyanate or amines but were occasionally exposed to fumes from heated thermo-Amines: possible causative agents in the development of bronchial hyperreactivity setting materials. They were treated in the same way as the polyurethane workers. To estimate the intraindividual variations in the spirometric parameters and to define low bronchial reactivity to 10 mg of inhaled methacholine, a second control group consisting of 24 healthy non-smoking subjects associated with our laboratory were selected. This group may reflect a "superhealthy" population because the criteria for entering the group were: no respiratory symptoms, no smoking, and no clinical signs of atopy.
ANALYSIS OF THE WORKING ATMOSPHERE
Isocyanates were sampled and analysed as described by Sango and Zimerson.20 Briefly, air was drawn through a midget impinger filled with 10 ml of reagent absorber solution at a flow rate of 1-0-1*5 /min. The isocyanates form stable derivatives with this reagent (9-(N-methylaminomethyl)-anthracene). The derivatives were analysed using high performance liquid chromatograpy (HPLC). The detection limit was about 0.1 ppb, based on a 15 1 air sample. The collection efficiency was more than 95%.
The amines were sampled in impinger vessels containing 0 1 N H2SO4. After alkalisation, N-methylmorpholine and DABCO were determined by direct injection. Hydrolysed TDI was determined after extraction of the alkalised amine solution. The relative standard deviation in the total analysis of triple injections of samples into the gas chromatograph was 5% in the first place and 8% in the analysis of TDI. The chromatographic measurements were made on a Varian 3700 gas chromatograph equipped with a Varian nitrogen sensitive detector (TSD) and an HP 3390 A integrator. This analysis is a further development of methods previously published by US.28 29 
Results

CLINICAL FINDINGS
Analysis of the relative standard deviation for the intraindividual variation of FEV, and MEF4o in the second control group (healthy, non-smoking individuals) showed that a decrease from baseline must be greater than 15% and 30% (> 2 CV \/2) respectively to be considered a significant ventilatory change. No one in the second control group had a reaction beyond these levels when challenged with 1 mg and 10 mg of methacholine. Thus individuals having a change from baseline of less than 15% for FEVY and 30% for MEF4o when challenged with 1 ml of a 10 mg/ml solution were classified as having a low methacholine reactivity. This group will also include individuals having no response to methacholine, but for statistical reasons (intraindividual variation) it was not possible to distinguish non-responders from low responders. We chose a 25% decrease in FEV, as the lower limit for increased reactivity. This limit corresponded to a 55% decrease in MEF4o since there was a correlation between FEV, and MEF4o among the examined workers (n = 73, r = 0-84, MEF4o = 1*7 x FEVY + 12). Increased reactivity was consequently defined as a decrease from baseline of FEV, or MEF4o by at least 25% or 55% respectively on challenge with 10 mg methacholine. Workers with a reactivity intermediate increased and low were considered to have a medium reactivity to methacholine. The above definitions are visualised in fig 1 . Table 1 shows the results of the medical investigation. Mean values of FEV, expressed as predicted normal were above 100% in all three groups.30 The second control group had a significantly higher value than the first control group (p < 0-05), whereas there was no such difference between the exposed group and the first control group. In both the exposed group and the first control group about 40% of the workers had a greater bronchial reactivity to 10 mg methacholine than any of the individuals in the second control group. Everyone included in this study participated on a voluntary basis. Four of 48 exposed workers and one of the 30 subjects in the first control group chose not to take part in the methacholine challenge test. The company nurse had the impression that these four exposed workers had respiratory symptoms and did not want to have these symptoms confirmed. Two of these four had a baseline FEV, value of less than 70% of the predicted value.
The prevalence of increased methacholine reactivity was higher in the exposed group than in the first control group (chi-square test, 0-05 < p < 0.07). Figure 2 shows the distribution of Air was drawn through a midget impinger filled with 10 ml of 0-1 N H2SO4 absorber solution. Figure 4 shows a typical chromatogram obtained in the GLC analysis, by direct injection, of the alkalised absorber solution. Typical sampling parameters were air flow 1.5 /min and sampling time 15 minutes with a sampling efficiency of more than 98%. Figure 5 shows the results from the GLC analysis of an extracted sample containing TDI, N-methylmorpholine, and DABCO. The extraction efficiency for TDI was about 100% with equal volumes and about 90% with an extraction volume of 1:10 of toluene to sample solution. The system in fig 4 was optimised for N-methylmorpholine and DABCO in a fashion that made the TDI peak unob- Pennwalt 223 + 4 % KOH on Gas Chrom R (80-100 mesh); 1 5 g in a glass column (100 cm x 2 mm id). Column programmed from 90°C (2 min) to 215°C (2 min), 16°Clmin. Injector: 290°C; detector: 3000C. Detector attenuation: 1.1 -I0 AFS integrator attenuation changed from 27 to 21 after 3 5 minutes and to 2-5 after eight minutes.
servable owing to the low concentration of this compound. The air concentrations found are summarised in table 2. A, B, and C refer to different operations in the production, as described above. The concentration of isocyanate decreased and the concentration of amines increased with the distance from the moulding. All values for TDI were well below 0-01 ppm, which is the Swedish threshold limit value (TLV). No detectable amounts of MDI or phenyl isocyanate were found using HPLC. The concentrations of N-methylmorpholine were about 10 times the TLV in force in the Soviet Union, which is 5 mg/m3, corresponding to about 1 ppm.31
No TLV for this substance exists in Sweden or, to our knowledge, in the United States. The TDI concentrations obtained with the HPLC and the GLC methods were in close agreement, but since only a few samples were taken simultaneously, no definite conclusions could be drawn on this point. We found combined work related symptoms from the eyes and the respiratory tract in a considerable number of workers exposed to the chemicals used in polyurethane production. Isocyanates and amines were the most likely causative agents. Although isocyanates are known potential sensitisers, we are inclined to believe that the amine exposure was an important cause of the symptoms, since the concentrations (ppm) of the amines were up to 10 000 times higher than those of the isocyanates, which were all well below the Swedish threshold level. The similar results obtained with the HPLC and GLC methods indicate that isocyanates were probably not hydrolysed to amines in this working atmosphere, but this will be investigated in future experiments. We cannot exclude the possibility that high isocyanate concentrations may have occurred during near accidents, but on these occasions extraordinary precautions were taken to minimise exposure.
During the medical field study we searched for signs of bronchial dysfunction by challenging the workers with only two doses of nebulised methacholine. This simplified procedure is faster than the collection of dose-response data on airway sensitivity by giving a series of challenge doses. It was chosen so that workers need not be away from production for too long. Although airway sensitivity to methacholine is often studied in occupational asthma, few population studies have been reported. Thus it seemed appropriate to use two different control groups for comparison of the results. In the first control group (production workers) mean of 255 baseline FEV,, expressed as a percentage of predicted normal, was significantly lower than in control group 2 (laboratory staff). Several of the workers in the first group decreased their FEV, more than 15% and MEF4o more than 30% on challenge with methacholine (10 mg). No such reaction was seen in any of the individuals in control group 2. Tobacco smoke, pyrolysis products, and industrial chemicals other than isocyanates and amines may account for the difference between our control groups. The lack of appreciable response in any of the individuals in control group 2 is probably also due to the fact that this group basically consisted of non-atopic individuals.
The study at the workplace showed that a considerably higher proportion of the workers exposed to isocyanate-amine reacted with a drop of FEV, or MEF4o exceeding 25% and 55% respectively from baseline on bronchial challenge with 10 mg of methacholine than did the first control group, matched for atopy and smoking. Comparison with the results from the second control group shows an even larger difference. This is a modest increase in reactivity compared with the bronchial hyperreactivity commonly seen in established bronchial asthma however, when pronounced reactions are often elicited by 10 to 100-fold lower doses. It is more comparable with the change of bronchial reactivity observed in healthy individuals after viral infections and exposure to SO2, NO2, or ozone. [37] [38] [39] It has been suggested that any noxious agent causing mucosal damage may increase bronchial reactivity as measured by lowered threshold levels to methacholine or histamine. 40 We believe that exposure to amines may cause such mucosal damage in workers producing polyurethane in a similar way to dimethylethanolamine, which has been shown to increase bronchial reactivity to histamine.24 Our suspicions concerning amines are strengthened by the fact that many of the workers also repeatedly had blurred vision, with blue haze or fog and haloes around lights. These are typical symptoms of transient oedema of the corneal epithelium and have been related to exposure to some amines, including N-methylmorpholine. 4'4 It is possible that corneal oedema (causing visual disturbances) and mucosal damage resulting in increased bronchial reactivity are common amine-induced delayed mucosal responses. The fact that eye symptoms were particularly frequent among subjects with increased methacholine reactivity seems to support this assumption. We believe that uncontrolled exposure to amine represents a substantial health hazard in workers engaged in the production of polyurethane. We 
